PLATELET TRANSFUSION AND ALTERNATIVES TO TRANSFUSION IN PATIENTS WITH MALIGNANCY

被引:1
作者
VAICKUS, L [1 ]
BREITMEYER, JB [1 ]
SCHLOSSMAN, RL [1 ]
ANDERSON, KC [1 ]
机构
[1] DANA FARBER CANC INST,BOSTON,MA 02115
关键词
PLATELETS; CYTOKINES; INTERLEUKIN; 6; THROMBOCYTOPENIA; THROMBOPOIETIN;
D O I
10.1002/stem.5530130603
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Platelet transfusions have long had an important role in the treatment of patients with thrombocytopenia due to disease or myelotoxic treatment or in patients with reduced platelet function, However, platelet transfusions are associated with numerous risks, both immunologic (e,g., transfusion reactions, alloimmunization, immunosuppression) and infectious (e,g,, viral, bacterial), In addition, several laboratory and clinical factors can influence post-transfusion platelet recovery, Recent technological advances have introduced the potential for using alternatives to platelet transfusions, such as cytokines or platelet substitutes, which may avoid the risks of transfusion, Platelet development from megakaryocytes is a process that is highly regulated by cytokines and animal research suggests that selected cytokines involved in this process may be useful in the treatment of thrombocytopenia, Newer developments, including the utilization of recombinant cytokines with relatively selective stimulation of platelet production (e,g., interleukin 6 [IL-6]) and the recent discovery of a megakaryocyte colony stimulating factor (thrombopoietin), represent major therapeutic opportunities in the treatment of thrombocytopenia, Platelet substitutes, e,g,, thromboerythrocytes, also show promise in the management of platelet deficiencies.
引用
收藏
页码:588 / 596
页数:9
相关论文
共 86 条
[1]   HEPATITIS-C VIRUS-INFECTION IN POSTTRANSFUSION HEPATITIS - AN ANALYSIS WITH 1ST-GENERATION AND 2ND-GENERATION ASSAYS [J].
AACH, RD ;
STEVENS, CE ;
HOLLINGER, FB ;
MOSLEY, JW ;
PETERSON, DA ;
TAYLOR, PE ;
JOHNSON, RG ;
BARBOSA, LH ;
NEMO, GJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (19) :1325-1329
[2]  
ANDERSON KC, 1991, BLOOD, V77, P2096
[3]   TRANSFUSION-RELATED SEPSIS AFTER PROLONGED PLATELET STORAGE [J].
ANDERSON, KC ;
LEW, MA ;
GORGONE, BC ;
MARTEL, J ;
LEAMY, CB ;
SULLIVAN, B .
AMERICAN JOURNAL OF MEDICINE, 1986, 81 (03) :405-411
[4]  
ANDERSON KC, 1988, TRANSFUSION MED, P145
[5]  
Anderson Kenneth, 1993, P2294
[6]  
ANDREU G, 1988, BLOOD, V72, P964
[7]   CONTROVERSIES IN TRANSFUSION MEDICINE - PROPHYLACTIC PLATELET TRANSFUSION THERAPY - PRO [J].
BAER, MR ;
BLOOMFIELD, CD .
TRANSFUSION, 1992, 32 (04) :377-380
[8]   STRATEGIES FOR THE AVOIDANCE OF BACTERIAL-CONTAMINATION OF BLOOD COMPONENTS [J].
BARRETT, BB ;
ANDERSEN, JW ;
ANDERSON, KC .
TRANSFUSION, 1993, 33 (03) :228-233
[9]  
BEUTLER E, 1993, BLOOD, V81, P1411
[10]  
BISHOP JF, 1988, BLOOD, V71, P383